Literature DB >> 18674680

Effect of contrast media on megavoltage photon beam dosimetry.

Ashley W Rankine1, Peter J Lanzon, Nigel A Spry.   

Abstract

The purpose of this study was to quantify changes in photon beam dosimetry caused by using contrast media during computed tomography (CT) simulation and determine if the resulting changes are clinically significant. The effect of contrast on dosimetry was first examined for a single 6-MV photon beam incident on a plane phantom with a structure of varying electron densities (rho(e)) and thickness. Patient studies were then undertaken in which CT data sets were collected with and without contrast for 6 typical patients. Three patients received IV contrast (Optiray-240) only and 3 received IV plus oral (Gastrograffin) contrast. Each patient was planned using conformal multifield techniques in accordance with the department standards. Two methods were used to compare the effect of contrast on dosimetry for each patient. The phantom analysis showed that the change in dose at the isocenter for a single 10 x 10 cm2 6-MV photon beam traversing 10 cm of a contrast-enhanced structure with rho(e) 1.22 was 7.0% (1.22 was the highest average rho(e) observed in the patient data). As a result of using contrast, increases in rho(e) were observed in structures for the 6 patients studied. Consequently, when using contrast-enhanced CT data for multifield planning, increases in dose at the isocenter and in critical structures were observed up to 2.1% and 2.5%, respectively. Planning on contrast-enhanced CT images may result in an increase in dose of up to 2.1% at the isocenter, which would generally be regarded as clinically insignificant. If, however, a critical organ is in close proximity to the planning target volume (PTV) and is planned to receive its maximum allowable dose, planning on contrast-enhanced CT images may result in that organ receiving dose beyond the recommended tolerance. In these instances, pre-contrast CT data should be used for dosimetry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674680     DOI: 10.1016/j.meddos.2007.04.007

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  5 in total

1.  Influence of the contrast agents on treatment planning dose calculations of prostate and rectal cancers.

Authors:  Sahel Heydarheydari; Negin Farshchian; Abbas Haghparast
Journal:  Rep Pract Oncol Radiother       Date:  2016-05-06

2.  The effect of bladder contrast on dose calculation in volumetric modulated arc therapy planning in patients treated for postoperative prostate cancer.

Authors:  Tülay Ercan; Şefik İğdem; Gül Alço
Journal:  Jpn J Radiol       Date:  2016-02-02       Impact factor: 2.374

3.  Intravenous contrast-enhanced cone beam computed tomography (IVCBCT) of intrahepatic tumors and vessels.

Authors:  Cynthia L Eccles; Regina V Tse; Maria A Hawkins; Mark T Lee; Douglas J Moseley; Laura A Dawson
Journal:  Adv Radiat Oncol       Date:  2016-01-26

4.  Impact on liver position under breath-hold by computed tomography contrast agents in stereotactic body radiotherapy of liver cancer.

Authors:  Hideharu Miura; Shuichi Ozawa; Minoru Nakao; Yoshiko Doi; Katsumaro Kubo; Masahiro Kenjo; Yasushi Nagata
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

5.  Dosimetric effect of CT contrast agent in CyberKnife treatment plans.

Authors:  Hee Jung Kim; Ah Ram Chang; Yang-Kyun Park; Sung-Joon Ye
Journal:  Radiat Oncol       Date:  2013-10-18       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.